22056 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Kris
    Kris
  5. Saltz
    Saltz
  6. Offit
    Offit
  7. O'Reilly
    O'Reilly
  8. Solit
    Solit
  9. Robson
    Robson
  10. Drilon
    Drilon

Groups

  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)
  7. Breast Medicine Service (4103)
  8. Surgery (4018)
  9. Department of Pathology and Laboratory Medicine (3422)
  10. Thoracic Oncology (3351)
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10830)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22056)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Important advances in the treatment of breast cancer
    Journal Article

    Hudis, C.
    Oncology (Norwalk) (2012)

    Fulltext@MSK | Save
  • The role of EGFR and KRAS mutations in locally advanced lung adenocarcinoma treated with definitive radiation therapy
    Meeting Abstract

    Rimner, A.; Wang, H.; Tsang, M.; Drilon, A.; Paik, P. K.; Hsu, M.; Zhang, Z.; Rosenzweig, K.; Wu, A. J.; Zakowski, M.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Evans, T. L.; Salgia, R.; Ou, S. I.; Gettinger, S. N.; Otterson, G. A.; Lanzalone, S.; Polli, A.; Shaw, A. T.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies
    Journal Article

    Sofocleous, C. T.; Garg, S.; Petrovic, L. M.; Gonen, M.; Petre, E. N.; Klimstra, D. S.; Solomon, S. B.; Brown, K. T.; Brody, L. A.; Covey, A. M.; more...
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CTLA-4 blockade for melanoma: Past, present and future
    Meeting Abstract

    Wolchok, J.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Resistance to RAF inhibitors due to RAS-independent dimerization of BRAF(V600E) splicing variants
    Meeting Abstract

    Poulikakos, P. I.; Persaud, Y.; Janakiraman, M.; Gabay, M. T.; Dahlman, K. B.; Sosman, J. A.; Ribas, A.; Lo, R. S.; Rosen, N.; Solit, D. B.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Patient selection markers for anti-angiogenic agents in metastatic renal cell carcinoma: Dream or reality?
    Meeting Abstract

    English, P. A.; Williams, J. A.; Martini, J. F.; Motzer, R. J.; Valota, O.; Buller, R. E.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save